Large gap with delayed quotes
|
Last quote
12/27/2024 -
16:15:00
|
Bid
12/27/2024 -
16:00:00
|
Bid Volume |
Ask
12/27/2024 -
16:00:00
|
Ask Volume |
|---|---|---|---|---|
|
83.56
-0.86
(
-1.02% )
|
83.50
|
3,300 |
83.51
|
5,900 |
Analysis date: 24.12.2024
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 06.12.2024.
Interest
Very weak
Very weak
Very weak interest since 06.12.2024.
Earnings Rev Trend
-0.10
-0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 08.10.2024 at a price of 70.06.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, at its current price the stock is moderately overvalued.
MT Tech Trend
Positive
Positive
The forty day Medium Term Technical Trend is positive since 23.08.2024. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 79.281.
4wk Rel Perf
-2.09%
-2.09%
The four week relative underperformance versus SP500 is 2.09%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 09.02.2024.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.28%.
Mkt Cap in $bn
11.32
11.32
With a market capitalization >$8bn, GLOBUS MEDICAL INCO. is considered a large-cap stock.
G/PE Ratio
0.85
0.85
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
21.23
21.23
The estimated PE is for the year 2026.
LT Growth
18.12%
18.12%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
14
14
Over the last seven weeks, an average of 14 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
99
99
For 1% of index variation, the stock varies on average by 0.99%.
Correlation
0.31
0.31
Stock movements are strongly independent of index variations.
Value at Risk
20.03
20.03
The value at risk is estimated at USD 20.03. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
27.07.2018
27.07.2018